Fonar CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
FONAR Corporation's Q3 2026 Form 10-Q reveals a slight revenue increase but a decrease in net income, alongside ongoing progress in a proposed going-private transaction.
NASDAQ
FONAR Corporation reported increased revenues but decreased net income for the six months ended December 31, 2025, as a proposed going-private transaction by its CEO progresses.
NASDAQ
FONAR Corporation reported a significant drop in Q1 net income and operating income, driven by increased costs, while a take-private proposal and government shutdown add uncertainty.
NASDAQ
FONAR Corporation's Q3 2025 results show a decrease in net income despite a slight revenue increase, driven by rising costs and expenses.
NASDAQ
FONAR Corporation's Q2 2025 results show a decrease in net income and revenue compared to the same period last year, primarily due to lower patient fee revenue and increased costs.
NASDAQ
FONAR Corporation's first quarter of fiscal year 2025 saw a decrease in revenue and operating income compared to the same period last year, despite an increase in scan volumes.
NASDAQ
Fonar Corporation's third quarter results for fiscal year 2024 showed increased revenue and operating income, driven primarily by growth in its diagnostic imaging management segment, despite headwinds from reduced reimbursement rates and inflation.
NASDAQ
FONAR Corporation's first half of fiscal year 2024 shows significant revenue and profit growth, primarily driven by increased patient fee revenue and effective cost management.